GSTM1 and chronic kidney disease: The baseline Hb level that met the recommended range of the Chinese renal anemia guideline was approximately 60%–63%, which was comparable to the Hb attainment rate of Japanese patients with CKD stages 3–4 and slightly higher than that of patients with CKD stages 3–4 in the United States (20, 21).